| In-vivo measurement of activated microglia in dementia A Cagnin, DJ Brooks, AM Kennedy, RN Gunn, R Myers, FE Turkheimer, ... The Lancet 358 (9280), 461-467, 2001 | 1334 | 2001 |
| In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease A Gerhard, N Pavese, G Hotton, F Turkheimer, M Es, A Hammers, ... Neurobiology of disease 21 (2), 404-412, 2006 | 1274 | 2006 |
| Inflammation after trauma: microglial activation and traumatic brain injury AF Ramlackhansingh, DJ Brooks, RJ Greenwood, SK Bose, ... Annals of neurology 70 (3), 374-383, 2011 | 1056 | 2011 |
| Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study MR Turner, A Cagnin, FE Turkheimer, CCJ Miller, CE Shaw, DJ Brooks, ... Neurobiology of disease 15 (3), 601-609, 2004 | 849 | 2004 |
| The peripheral benzodiazepine binding site in the brain in multiple sclerosis: Quantitative in vivo imaging of microglia as a measure of disease activity RB Banati, J Newcombe, RN Gunn, A Cagnin, F Turkheimer, F Heppner, ... Brain 123 (11), 2321-2337, 2000 | 772 | 2000 |
| Homological scaffolds of brain functional networks G Petri, P Expert, F Turkheimer, R Carhart-Harris, D Nutt, PJ Hellyer, ... Journal of The Royal Society Interface 11 (101), 20140873, 2014 | 726 | 2014 |
| Emergence of resting state networks in the preterm human brain V Doria, CF Beckmann, T Arichi, N Merchant, M Groppo, FE Turkheimer, ... Proceedings of the National Academy of Sciences 107 (46), 20015-20020, 2010 | 627 | 2010 |
| Conversion of amyloid positive and negative MCI to AD over 3 years: An 11C-PIB PET study A Okello, J Koivunen, P Edison, HA Archer, FE Turkheimer, K Nagren, ... Neurology 73 (10), 754-760, 2009 | 627 | 2009 |
| Microglia, amyloid, and cognition in Alzheimer's disease: An [11C](R) PK11195-PET and [11C] PIB-PET study P Edison, HA Archer, A Gerhard, R Hinz, N Pavese, FE Turkheimer, ... Neurobiology of disease 32 (3), 412-419, 2008 | 619 | 2008 |
| Microglial activation correlates with severity in Huntington disease: a clinical and PET study N Pavese, A Gerhard, YF Tai, AK Ho, F Turkheimer, RA Barker, DJ Brooks, ... Neurology 66 (11), 1638-1643, 2006 | 538 | 2006 |
| Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [11C]PBR28 PET Brain Imaging Study PS Bloomfield, S Selvaraj, M Veronese, G Rizzo, A Bertoldo, DR Owen, ... American Journal of Psychiatry 173 (1), 44-52, 2016 | 488 | 2016 |
| Redefining the functional organization of working memory processes within human lateral prefrontal cortex AM Owen, NJ Herrod, DK Menon, JC Clark, SPMJ Downey, TA Carpenter, ... European Journal of Neuroscience 11 (2), 567-574, 1999 | 426 | 1999 |
| Dopamine Synthesis Capacity Before Onset of Psychosis: A Prospective [18F]-DOPA PET Imaging Study OD Howes, SK Bose, F Turkheimer, I Valli, A Egerton, LR Valmaggia, ... American Journal of Psychiatry 168 (12), 1311-1317, 2011 | 424 | 2011 |
| Microglial activation and amyloid deposition in mild cognitive impairment: a PET study A Okello, P Edison, HA Archer, FE Turkheimer, J Kennedy, R Bullock, ... Neurology 72 (1), 56-62, 2009 | 405 | 2009 |
| Reference and target region modeling of [11C]-(R)-PK11195 brain studies FE Turkheimer, P Edison, N Pavese, F Roncaroli, AN Anderson, ... Journal of Nuclear Medicine 48 (1), 158-167, 2007 | 342 | 2007 |
| Converging language streams in the human temporal lobe G Spitsyna, JE Warren, SK Scott, FE Turkheimer, RJS Wise Journal of Neuroscience 26 (28), 7328-7336, 2006 | 341 | 2006 |
| Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study O Howes, S Bose, F Turkheimer, I Valli, A Egerton, D Stahl, L Valmaggia, ... Molecular psychiatry 16 (9), 885-886, 2011 | 325 | 2011 |
| Positron emission tomography compartmental models: a basis pursuit strategy for kinetic modeling RN Gunn, SR Gunn, FE Turkheimer, JAD Aston, VJ Cunningham Journal of Cerebral Blood Flow & Metabolism 22 (12), 1425-1439, 2002 | 292 | 2002 |
| Microglia, amyloid, and glucose metabolism in Parkinson’s disease with and without dementia P Edison, I Ahmed, Z Fan, R Hinz, G Gelosa, K Ray Chaudhuri, Z Walker, ... Neuropsychopharmacology 38 (6), 938-949, 2013 | 267 | 2013 |
| Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson’s disease patients M Politis, K Wu, C Loane, DJ Brooks, L Kiferle, FE Turkheimer, P Bain, ... The Journal of clinical investigation 124 (3), 1340-1349, 2014 | 266 | 2014 |
